The Filing Desk

Bionano Genomics vs Seer

Bionano Genomics BNGO · Seer SEER · Life Sciences Tools & Services

Bionano Genomics reported revenue of $28 million in fiscal 2025, 1.7 times Seer's $17 million in fiscal 2025. Bionano Genomics' revenue fell 7.4% in its latest year, and Seer's grew 17.0%. Bionano Genomics had an operating margin of -117.0%, against -470.4% at Seer. Free cash flow was −$16 million at Bionano Genomics and −$46 million at Seer.

Side by side

Bionano GenomicsSeer
Latest fiscal yearFY2025, Dec 31, 2025FY2025, Dec 31, 2025
Revenue$28M$17M
Revenue growth−7.4%17.0%
Revenue growth a year, last 5 years27.4%88.4%
Gross margin46.2%51.1%
Operating margin−117.0%−470.4%
Net margin−92.6%−444.0%
Free cash flow−$16M−$46M
Free cash flow margin−57.3%−278.9%
Return on capital−89.9%—
Net debt to EBITDA——
Dividends and buybacks$0M$0M
Change in diluted share count328.4%—
Last close$0.89$1.39
P/E at the last close——
Insider trades, last 12 months—sold $117,931
Piotroski F-score5 of 9—
Amounts in each company's own currency, US$ unless marked (a foreign company may report in another), each company's latest fiscal year from its 10-K, or 20-F or 40-F for a foreign company. Growth rates compare with the year before; the five-year rate is the average a year. Free cash flow is cash from operations minus capital spending; return on capital is after-tax operating income over the money invested in the business; P/E is the last close over the latest earnings per share. Banks are measured differently (return on equity, efficiency ratio), so some rows apply to one company only.

Ten years

Revenue
US$ billions, fiscal years
Bionano GenomicsSeer
Operating margin
Percent of revenue
Bionano GenomicsSeer
Free cash flow
US$ billions. Cash from operations minus capital expenditure.
Bionano GenomicsSeer

Start a new comparison

Source: the companies' Form 10-K filings, from SEC EDGAR, and the last close. For information only, not investment advice: the figures describe results, not which company is the better investment. The Filing Desk is not affiliated with either company. Full figures on the Bionano Genomics and Seer pages.